Stock Information
Royalty Pharma PLC (RPRX)
Ticker Symbol: RPRX
Exchange: NASDAQ
Sector: N/A
Market Cap: $23,426.11 mil
Piotroski score: 5
PE Ratio: 34.0117
EPS (TTM): 1.3343
Revenue (TTM): $4.20 M
Dividend Yield: 2.0982141%
ROE: 11.59%
Latest News
-
Dividend Champion, Contender, And Challenger Highlights: Week Of February 15
Fri, Feb 13, 2026 6:33 PM
-
Royalty Pharma: Strong Execution And Visible Pipeline Support Our Buy View
Thu, Feb 12, 2026 12:16 PM
-
Royalty Pharma plc (RPRX) Q4 2025 Earnings Call Transcript
Wed, Feb 11, 2026 4:44 PM
-
Royalty Pharma PLC-CL A (NASDAQ:RPRX) Shares Dip Despite Strong Portfolio Growth and 2026 Guidance Beat
Wed, Feb 11, 2026 1:20 PM
-
Royalty Pharma plc 2025 Q4 - Results - Earnings Call Presentation
Wed, Feb 11, 2026 9:01 AM
-
Royalty Pharma Q4 Earnings Report: What Investors Need to Know
Wed, Feb 11, 2026 8:06 AM
-
Royalty Pharma Q4 Adj. EPS $1.47 Beats $1.33 Estimate, Sales $622.000M Miss $795.915M Estimate
Wed, Feb 11, 2026 8:04 AM
-
Earnings Scheduled For February 11, 2026
Wed, Feb 11, 2026 7:11 AM
-
Royalty Pharma's Earnings: A Preview
Tue, Feb 10, 2026 11:01 AM
Key Financials
Financial data not available
